NGM Biopharmaceuticals Inc (NASDAQ:NGM)

5.40
Delayed Data
As of Feb 06
 0.00 / 0.00%
Today’s Change
2.92
Today|||52-Week Range
18.25
+7.57%
Year-to-Date
No recent news for NGM Biopharmaceuticals Inc.

Today’s Trading

Previous close5.40
Today’s open5.37
Day’s range5.31 - 5.42
Volume8,341
Average volume (3 months)785,710
Market cap$441.3M
Data as of 3:59pm ET, 02/06/2023

Growth & Valuation

Earnings growth (last year)-4.30%
Earnings growth (this year)-35.04%
Earnings growth (next 5 years)--
Revenue growth (last year)-10.86%
P/E ratioNM
Price/Sales17.53
Price/Book1.25

Competitors

----
WVEWAVE Life Sciences L...-0.07-1.36%
KODKodiak Sciences Inc-0.62-7.23%
PGENPrecigen Inc+0.09+4.92%
Data as of 4:00pm ET, 02/06/2023

Financials

Next reporting dateMarch 1, 2023
EPS forecast (this quarter)-$0.52
Annual revenue (last year)$77.9M
Annual profit (last year)-$120.3M
Net profit margin-154.51%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
South San Francisco, California

Forecasts